News

15 Nov 2019

4Dx Completes FDA Submission Documentation

FOR IMMEDIATE RELEASE As of November 10, 2019, 4Dx is proud to announce that all documents required to support an FDA 510(k) application have been handed over to its agent for electronic submission. After a tremendously successful clinical validation trial, 4Dx founder and CEO, Andreas Fouras, was very happy to announce the trial’s results, which […]

READ POST
12 Nov 2019

Dr. Sam Hupert, CEO of Pro Medicus, Joins 4Dx Advisory Board

4Dx is pleased to announce the appointment of Dr. Sam Hupert, co-Founder and CEO of Pro Medicus (ASX: PME) to the 4Dx advisory board. Dr. Hupert has made a private investment into 4Dx and agreed to sit on 4Dx’s advisory board, bringing with him more than 37 years of success as a leader in the global […]

READ POST
05 Nov 2019

Biotech Daily – “4DX: ‘XV BEATS PFT, CT FOR LUNG HEALTH’”

From Biotech Daily – released Friday, November 1, 2019   4DX LIMITED 4DX says a 32-patient, 13-month study shows that its XV technology is superior to “gold standard pulmonary diagnostics” to measure lung health. 4DX said the study, titled ‘Novel x-ray velocimetry based quantitative regional lung function analysis to assess risk of radiation-induced pneumonitis and […]

READ POST
31 Oct 2019

New 4Dx article on Stockhead website

A new article was posted today on Stockhead.com, an online health & technology news service focusing on big discoveries, medical breakthroughs and revolutionary technologies. Check it out! 4Dx’s lung imaging technology just passed a clinical trial. Next step — an ASX listing

READ POST
19 May 2019

4Dx Presents First Human Scan Data From XV Technology Clinical Trials

Andreas Fouras, PhD, (founder and CEO of 4Dx) presented this week the first release of the highly anticipated results from 4Dx’s clinical trials at the American Thoracic Society (ATS) 2019 International Conference in Dallas, TX, 4Dx opened Day 1 of the 3-day conference with a newly-designed booth dedicated to showcasing the first of many 4-dimensional […]

READ POST
26 Apr 2019

FUNDING FOR GROUND-BREAKING LUNG DIAGNOSTIC TECHNOLOGY

 The Hon. Greg Hunt MP  Minister for Health  MEDIA RELEASE  FUNDING FOR GROUND-BREAKING LUNG DIAGNOSTIC TECHNOLOGY  The Liberal National Government will provide $960,000 for intensive research into new 4D diagnostic technology to allow accurate assessment of lung function in patients of all ages including the very sick.  The Australian Lung Health Initiative headed by Professor […]

READ POST
23 Nov 2018

Wind Tunnel Technology Fights Lung Disease

Headquartered in Westlake Village, CA, 4DX developed a medical technology that has the capacity to simply, safely, and effectively view lung air flow function in fine detail.   Andreas Fouras, CEO of 4DX, and a mechanical engineer by training, is behind this innovation. While working at a major university in Australia in wind tunnel research, […]

READ POST
10 Sep 2018

Radiology Today Magazine: More With Less

Advanced software reduces dose without sacrificing image quality.   Although the direct health risk of medical diagnostic scanning is not unequivocally clear, it is important for patients as well as health care professionals to mitigate the risks of radiation dose. While most of the concern regarding overexposure and cumulative dose has historically been focused on […]

READ POST
24 Aug 2018

MD+DI Online Interview: An Australian Startup’s Unique Approach to Imaging Lung Function

4Dx has developed an algorithm-based software that converts X-ray images into more detailed airflow studies. 4Dx is developing a software-as-a-service technology that enables four-dimensional lung imaging tests using the imaging equipment already in place at hospitals and other clinical settings. The company expects to have FDA clearance for the software sometime in 2019. Here’s a […]

READ POST
07 Aug 2018

Medical imaging startup takes new approach to viewing lung disease

The company’s algorithms use existing fluoroscopy technology, which captures structures in motion and is commonly used to image the cardiovascular system or direct invasive procedures.   Lung diseases, like asthma, cystic fibrosis (CF) and COPD, affect millions of people worldwide. However, current diagnostics don’t necessarily provide enough data to support the best possible care. Spirometry […]

READ POST